|
RBL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.46519999969053E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.67160000022982E-07 |
| Normal-vs-Stage2 |
2.747600E-02 |
| Normal-vs-Stage3 |
2.570700E-04 |
| Normal-vs-Stage4 |
1.5164000000123E-06 |
| Stage1-vs-Stage2 |
7.251000E-01 |
| Stage1-vs-Stage3 |
4.356200E-01 |
| Stage1-vs-Stage4 |
2.293000E-01 |
| Stage2-vs-Stage3 |
3.764600E-01 |
| Stage2-vs-Stage4 |
1.704010E-01 |
| Stage3-vs-Stage4 |
4.879600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.83480000004455E-06 |
| Normal-vs-AfricanAmerican |
2.89899999994514E-06 |
| Normal-vs-Asian |
1.220890E-03 |
| Caucasian-vs-AfricanAmerican |
4.227600E-01 |
| Caucasian-vs-Asian |
6.507800E-01 |
| AfricanAmerican-vs-Asian |
7.886400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.30280000010252E-07 |
| Normal-vs-Female |
2.664100E-03 |
| Male-vs-Female |
3.614400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.52589999816655E-08 |
| Normal-vs-Extreme_Weight |
3.63880000020522E-07 |
| Normal-vs-Obese |
1.223970E-03 |
| Normal-vs-Extreme_Obese |
4.915800E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.920200E-01 |
| Normal_Weight-vs-Obese |
3.546400E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.301200E-01 |
| Extreme_Weight-vs-Obese |
2.029800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.139200E-01 |
| Obese-vs-Extreme_Obese |
4.671200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.608600E-04 |
| Normal-vs-Age(41-60Yrs) |
8.964600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.5262999997212E-07 |
| Normal-vs-Age(81-100Yrs) |
2.29590000011548E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.173000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.430600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.868100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.448000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.504400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.083200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.42940000000558E-05 |
| Normal-VS-Type2 PRCC |
5.2824999929868E-10 |
| Normal-VS-KIRP CIMP |
2.160800E-04 |
| Normal-VS-Unclassified PRCC |
3.810200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.797700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.561400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.889200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.739600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.118270E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.108300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.22610000047518E-07 |
| Normal-vs-N1 |
1.7101000000519E-06 |
| Normal-vs-N2 |
8.37350000000292E-05 |
| N0-vs-N1 |
8.463600E-01 |
| N0-vs-N2 |
4.281800E-01 |
| N1-vs-N2 |
2.605000E-01 |
|
|
